|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Cascadian Therapeutics, Inc (CASC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
50,560,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.02 - $10.02 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Love Ted W |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
37,878 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
11,896 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
14,161 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
19,225 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
21,490 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
58,404 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
60,669 |
|
- |
|
| Fyfe Gwen A. |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
10,125 |
|
- |
|
| Fyfe Gwen A. |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
12,390 |
|
- |
|
| Love Ted W |
Director |
– • – |
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
28,820 |
|
- |
|
| Love Ted W |
Director |
– • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
29,357 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
5,103 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
5,640 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
12,432 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
12,969 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
51,611 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
52,148 |
|
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2017-05-12 |
4 |
B |
$4.00 |
$11,192 |
D/D |
2,800 |
44,216 |
2.81 |
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2017-03-31 |
4 |
B |
$4.11 |
$8,229 |
D/D |
2,000 |
41,416 |
2.81 |
- |
|
| Fyfe Gwen A. |
Director |
– • – |
2017-03-28 |
4 |
B |
$4.12 |
$6,857 |
D/D |
1,666 |
3,332 |
2.39 |
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2017-03-20 |
4 |
B |
$3.93 |
$3,927 |
D/D |
1,000 |
39,416 |
2.73 |
- |
|
| James Steven P |
Director |
– • – |
2017-03-12 |
4 |
D |
$4.35 |
$5,063 |
D/D |
(1,164) |
3,492 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,656 |
4,656 |
|
- |
|
| Walker Luke Nathaniel |
SVP, Clinical DevelopmentOffic |
• – – |
2017-03-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,990 |
|
- |
|
| Love Ted W |
Director |
– • – |
2017-02-02 |
4 |
B |
$4.24 |
$97,520 |
D/D |
23,000 |
27,209 |
2.39 |
- |
|
221 Records found
|
|
Page 3 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
